Clinical Trials Directory

Trials / Completed

CompletedNCT05043896

The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction

The Effect of Combination Therapy Using Li-ESWT (Low Intensity Extracorporeal Shockwave Therapy) and PDE-5 Inhibitor in Patients With Erectile Dysfunction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Dr. Soetomo General Hospital · Other Government
Sex
Male
Age
40 Years – 55 Years
Healthy volunteers
Not accepted

Summary

to compare the effect of combination of li-eswt and pde-5 inhibitor to pde-5 alone in erectile dysfunction patients

Detailed description

Comparing the effect of Combination therapy (Li-ESWT combined with PDE5-inhibitor) vs SIngle therapy (PDE5-inhibitor) in mild to moderate Erectile Dysfunction patients. Parameters used for comparation are EHS score, IIEF-5 score, VEGF level and PSV

Conditions

Interventions

TypeNameDescription
PROCEDURELi-ESWTLi-ESWT twice weekly for 4 weeks
DRUGTadalafil 2.5Mg Tabtadalafil 2.5mg once daily

Timeline

Start date
2019-12-10
Primary completion
2020-06-03
Completion
2020-06-30
First posted
2021-09-14
Last updated
2021-09-14

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT05043896. Inclusion in this directory is not an endorsement.

The Effect of Combination Therapy Using Li-ESWT and PDE-5 Inhibitor in Patients With Erectile Dysfunction (NCT05043896) · Clinical Trials Directory